Company / CapEx per Share
Rani Therapeutics Holdings, Inc. CapEx per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$9.41
FY2025
5-year range
$0.06 / $48.19
FY2021-FY2025
Trend
-80.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $25.90 to $9.41 over the past 3 years.
Based on SEC 10-K filings.
9.41 in FY2025 with a 3-year CAGR of -28.6%.
Declined from $25.90 to $9.41 over the past 3 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -28.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capex per share decreased 80.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.41 | -80.5% |
| FY2024 | $48.19 | +86.0% |
| FY2022 | $25.90 | +42066.7% |
| FY2021 | $0.06 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026